A Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil in Chemotherapy Exposed Breast Cancer Survivors With Cognitive Impairment
Phase of Trial: Phase III
Latest Information Update: 17 Jul 2017
At a glance
- Drugs Donepezil (Primary)
- Indications Cognition disorders
- Focus Therapeutic Use
- 11 Jul 2017 Status changed from not yet recruiting to recruiting.
- 18 Apr 2017 Planned initiation date changed from 1 Sep 2016 to 1 Jul 2017.
- 14 Jul 2016 New trial record